Search

Your search keyword '"Urena-Torres, P"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Urena-Torres, P" Remove constraint Author: "Urena-Torres, P"
86 results on '"Urena-Torres, P"'

Search Results

1. Combining robust urine biomarkers to assess chronic kidney disease progressionResearch in context

2. Worldwide Early Impact of COVID-19 on Dialysis Patients and Staff and Lessons Learned: A DOPPS Roundtable Discussion

8. The 'FIFTY SHADOWS' of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease

12. The Non-invasive Diagnosis of Bone Disorders in CKD

13. Bone Fragility Fractures in CKD Patients

14. La calciphylaxie urémique.

15. Bone, inflammation and chronic kidney disease

19. Circulating markers of bone turnover

20. Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial

21. Potentielle application de l'axe fibroblast growth factor 23-Klotho dans la maladie rénale chronique.

22. Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement

24. Magnesium-based interventions for normal kidney function and chronic kidney disease

25. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part II): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification

26. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

27. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

28. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

29. Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease

30. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

31. Vascular calcification: from pathophysiology to biomarkers

35. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

43. Place de la vitamine D native en dialyse.

45. Multiphasic effects of blood pressure on survival in hemodialysis patients

46. Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry

47. Pharmacologic Role of Vitamin D Natural Products

48. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.

49. Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: Appropriate indications for a reasoned reimbursement of serum vitamin D measurement | Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phosphocalcique: Les bonnes indications pour un remboursement raisonné du dosage de vitamine D

50. Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: Appropriate indications for a reasoned reimbursement of serum vitamin D measurement,Ostéopathies fragilisantes, maladie rénale chronique, malabsorptions, anomalies biologiques du métabolisme phosphocalcique: Les bonnes indications pour un remboursement raisonné du dosage de vitamine D

Catalog

Books, media, physical & digital resources